Author

Leela Talluri

Institution: Hetero Drugs (India)

Observed institutions: Siddhartha Medical College, Gandhi Medical College & Hospital, Sir Sayajirao General Hospital Medical College, Sardar Patel Medical College, Osmania General Hospital, Ganesh Shankar Vidyarthi Memorial Medical College, Sawai Man Singh Hospital, Institute of Post Graduate Medical Education and Research, Jammu Hospital, Hetero Drugs (India), King George Hospital, School of Management Sciences, Varanasi, Post Graduate Institute of Medical Education and Research

ORCID: 0000-0001-8503-7897

Observed ORCID: 0000-0001-8503-7897

OpenAlex ID: A5014448801

Efficacy and Safety of Molnupiravir in Mild COVID-19 Patients in India

2022 · Shubhadeep Sinha, Kumarasamy N, et al. · Cureus · 31

Efficacy and safety of fixed-dose combination of Bilastine-Montelukast in adult patients with allergic rhinitis: a phase III, randomized, multi-center, double-blind, active controlled clinical study

2023 · Shubhadeep D. Sinha, Sridevi Perapogu, et al. · Journal of Asthma · 9

Efficacy and Safety of Acotiamide Versus Mosapride in Patients With Functional Dyspepsia Associated With Meal-Induced Postprandial Distress Syndrome: A Phase III Randomized Clinical Trial

2021 · Shubhadeep Sinha, Sreenivasa Chary, et al. · Cureus · 6

A Phase III Prospective Active and Placebo-Controlled Randomized Trial of Vilazodone in the Treatment of Major Depressive Disorder

2021 · Shubhadeep Sinha, Sreenivasa Chary, et al. · Cureus · 6

Comparative evaluation of efficacy, pharmacodynamics, and safety of Hetero’s adalimumab (Mabura®, Hetero Biopharma Ltd.) and reference adalimumab (Humira®, Abbvie Inc.) in patients with active rheumatoid arthritis on concomitant methotrexate therapy

2020 · Shubhadeep Sinha, Biswadip Ghosh, et al. · BMC Rheumatology · 6

Evaluation of the Efficacy and Safety of Azilsartan in Adult Patients with Essential Hypertension: A Randomized, Phase-III Clinical Study in India.

2021 · Shubhadeep Sinha, Sreenivasa Chary, et al. · PubMed · 5

A Real-World Study of Safety, Immunogenicity and Efficacy of Bevacizumab in Patients With Solid Malignancies: A Phase IV, Post-Marketing Study in India

2023 · Shubhadeep D Sinha, Ghanashyam Biswas, et al. · Cancer Informatics · 2

Efficacy and Safety of Orally Administered Acotiamide Extended-Release Tablets Among Functional Dyspepsia-Postprandial Distress Syndrome Patients: A Randomized, Double-Blind, Multicenter Study

2021 · Shubhadeep D Sinha, Saroj K Sinha, et al. · Cureus · 2

Safety, Tolerability, and Immunogenicity of Prescribed Usage of Darbepoetin-Alfa (Hetero Biopharma) in Patients of Chronic Kidney Disease With Renal Anemia: A Post-Marketing Surveillance Study

2021 · Shubhadeep Sinha, Vamsi Krishna Bandi, et al. · Cureus · 1

Mental Illness: A Review of Causes, Types, and Medicinal Plant Based Therapeutic Interventions

2023 · Nehasvita Veeramachaneni, Sujana Veeramachaneni, et al. · Research in psychology and behavioral sciences

Safety and tolerability of prescribed usage of Derise® (Darbepoetin Alfa, Hetero) in symptomatic anemia: A Phase IV Post-Authorization Study

2020 · Shubhadeep Sinha, Vamsi Krishna Bandi, et al.

Works count: 11

Citation count: 68

H-index: 5

I10-index: 1